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Background:  Patients with complicated Type B Acute Aortic Dissection (TBAAD) should receive an intervention.
methods:  TBAAD patients enrolled in the International Registry of Acute Aortic Dissection were split by time (T1=1996-2001, T2=2002-
2007, N=, T3=2008-2013) and stratified by those who received interventions.
results:  No difference was noted in age, gender, or patient history. Overall, TBAAD patients received more interventions over time (29.7% 
T1, N=149; 39.2% T2, N=203; 39.5% T3, N=181; p=0.001, trend p=0.001). TEVAR and/or fenestration increased (12.6% T1, N=63; 25.1% 
T2, N=130; 32.3% T3, N=148; p<0.001, trend p<0.001) while surgery decreased (17.2% T1, N=86; 14.1% T2, N=73; 7.2% T3, N=33; 
p<0.001, trend p<0.001). Interventional in-hospital mortality did not differ (19.5% T1, 10.3% T2, 13.8% T3, p=0.052, trend p=0.177). In 
a climate of increasing interventions, overall TBAAD in-hospital mortality did not change (12.4% T1, 8.1% T2, 11.8% T3, p=0.058, trend 
p=0.722). Later time periods demonstrated shorter median length of stay (16.0 T1, 14.0 T2, 13.0 T3, p<0.001) and lower post-discharge 
mortality (figure).
conclusion:  We identified divergent trends in TBAAD management. Early mortality did not change as interventions increased and post-
discharge survival improved. Despite the survival advantages of TEVAR v. surgery, complicated TBAAD carries high risk. With recent 
evidence showing improved long-term survival with TEVAR, our data supports an increasing use of this technology.
